Quality & Compliance
Inter-Pharma helps companies embed quality not only in documentation, but effectively in daily operations.
Discuss your project →Inter-Pharma expertise
The initial brief records the legal entity and sites, wholesale-authorisation scope, products and temperature ranges, processes, systems, quality events, outsourced activities, available SOPs and records, intended deliverables and acceptance owners. Gaps and assumptions remain explicit before design starts.
The quality system, Responsible Person and operational roles are defined so approvals, escalation, deputies, training and documented decisions work in daily wholesale, storage and transport activities.
Temperature events, process errors, damaged goods or missing evidence are contained and risk assessed. Root-cause analysis, corrective and preventive actions receive owners, deadlines and a documented effectiveness check.
Products, suppliers, routes, premises, systems and service providers are assessed before implementation. Change control connects risk, validation or qualification, training, approval and post-implementation review.
Authorisation status, scope, quality system and risk determine qualification, audit and monitoring. Quality agreements allocate data, deviations, subcontracting, escalation and each party's duties.
A risk-based audit programme, trendable metrics and periodic management review expose weaknesses and follow actions through to evidence-based closure.
A project can deliver a QMS gap assessment, process map, SOP and role architecture, deviation and CAPA workflow, change control, partner qualification, audit readiness and management review. Regulatory statements are checked against the current official GDP guideline; this is not legal advice.
EU guidelines on Good Distribution Practice of medicinal products for human use →
The linked European Commission text is the primary professional source; project-specific duties and national requirements are checked separately.
This page directly addresses the following professional and commercial searches:
GDP quality management pharma is relevant when product, regulatory status, temperature, volume, recipients, target markets and required process steps need to be assessed together. Inter-Pharma confirms the exact scope only after this project review.
At minimum, provide product type and status, temperature range, average and maximum stock, SKU and movements, recipients and destination countries, requested start, interfaces and additional services.
We structure your needs and connect the right partners and processes.